Cargando…

Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study

BACKGROUND: Idiopathic membranous nephropathy (IMN) is a major cause of nephrotic syndrome among adults. Considering the natural course of IMN, when to treat and with which immunosuppressive treatment need to be carefully considered in such patients. A combination of tripterygium wilfordii multiglyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shanshan, Li, Xiayu, Li, Heng, Liang, Qian, Chen, Jun, Chen, Jianghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669631/ https://www.ncbi.nlm.nih.gov/pubmed/26637482 http://dx.doi.org/10.1186/s12882-015-0199-x

Ejemplares similares

Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial
por: Geng, Chanyu, et al.
Publicado: (2022)

Tripterygium wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy: A protocol for a systematic review and meta-analysis
por: Jin, Yuxia, et al.
Publicado: (2020)

Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy
por: Shang, Shun-Lai, et al.
Publicado: (2018)

Proteomics analysis reveals novel insights into the mechanism of hepatotoxicity induced by Tripterygium wilfordii multiglycoside in mice
por: Miao, Yingying, et al.
Publicado: (2022)

Therapeutic effect of Tripterygium wilfordii Hook F multiglycosides on gut barrier dysfunction in rats with acute necrotizing pancreatitis
por: WANG, JIE, et al.
Publicado: (2013)

Mechanism of action of Tripterygium wilfordii for treatment of idiopathic membranous nephropathy based on network pharmacology
por: Shi, Honghong, et al.
Publicado: (2022)

The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy
por: Liang, Qian, et al.
Publicado: (2017)

Molecular mechanism of Cuscutae semen–radix rehmanniae praeparata in relieving reproductive injury of male rats induced with tripterygium wilfordii multiglycosides: A tandem mass tag-based proteomics analysis
por: Han, Shanshan, et al.
Publicado: (2023)

Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis
por: Wang, Hongyun, et al.
Publicado: (2023)

Calcineurin inhibitor therapy in combination with Tripterygium wilfordii polyglycoside tablets for idiopathic membranous nephropathy: A retrospective clinical observation
por: Gao, Ying, et al.
Publicado: (2021)

Effect of Cordyceps sinensis and Tripterygium wilfordii polyglycosidium on podocytes in rats with diabetic nephropathy
por: HAO, LI, et al.
Publicado: (2014)

Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
por: Lin, Na, et al.
Publicado: (2021)

Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
por: Wang, Lin, et al.
Publicado: (2021)

Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial
por: Ge, Yongchun, et al.
Publicado: (2013)

Based on Network Pharmacology Tools to Investigate the Mechanism of Tripterygium wilfordii Against IgA Nephropathy
por: Xia, Ming, et al.
Publicado: (2021)

The Active Compounds and Therapeutic Target of Tripterygium wilfordii Hook. f. in Attenuating Proteinuria in Diabetic Nephropathy: A Review
por: Liu, Peng, et al.
Publicado: (2021)

Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial
por: Lengnan, Xu, et al.
Publicado: (2020)

Mechanistic analysis for the origin of diverse diterpenes in Tripterygium wilfordii
por: Tu, Lichan, et al.
Publicado: (2022)

The genome of Tripterygium wilfordii and characterization of the celastrol biosynthesis pathway
por: Pei, Tianlin, et al.
Publicado: (2021)

The effect and safety of low-dose Tripterygium wilfordii in patients with type 2 diabetic nephropathy: A meta-analysis
por: Chen, Yixuan, et al.
Publicado: (2022)

Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria
por: Guo, Yuanyuan, et al.
Publicado: (2021)

Native Endophytes of Tripterygium wilfordii-Mediated Biotransformation Reduces Toxicity of Celastrol
por: Ma, Ping-yang, et al.
Publicado: (2022)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

Immunosuppressive Sesquiterpene Pyridine Alkaloids from Tripterygium wilfordii Hook. f.
por: Wang, Yadan, et al.
Publicado: (2022)

Investigating the Catalytic Activity of Glycosyltransferase on Quercetin from Tripterygium wilfordii
por: Gao, Jie, et al.
Publicado: (2020)

The complete chloroplast genome of Tripterygium wilfordii Hook. f. (Celastraceae)
por: Zhong, Yuan, et al.
Publicado: (2022)

Screening of major hepatotoxic components of Tripterygium wilfordii based on hepatotoxic injury patterns
por: Li, Meng, et al.
Publicado: (2023)

Molecular Cloning and Characterisation of Farnesyl Pyrophosphate Synthase from Tripterygium wilfordii
por: Zhao, Yu-Jun, et al.
Publicado: (2015)

New 18(4→3)-Abeo-Abietanoids from Tripterygium wilfordii
por: Ni, Lin, et al.
Publicado: (2018)

Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii
por: Ji, Wei, et al.
Publicado: (2010)

Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy
por: Cui, W., et al.
Publicado: (2017)

Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of Tripterygium wilfordii (Lév.) Hutch Against IgA Nephropathy
por: Zhao, Juanyong, et al.
Publicado: (2023)

Tripterygium wilfordii Hook. f. Preparations for Rheumatoid Arthritis: An Overview of Systematic Reviews
por: Li, Huimin, et al.
Publicado: (2022)

Efficacy and Safety of Glycosides of Tripterygium wilfordii Combined with Renin-Angiotensin System in the Treatment of IgA Nephropathy: A Systematic Review and Meta-Analysis
por: Chen, Ming, et al.
Publicado: (2022)

Preparation and Characterization of Tripterygium wilfordii Multi-Glycoside Nanoparticle Using Supercritical Anti-Solvent Process
por: Chen, Fengli, et al.
Publicado: (2014)

Case report: remarkable remission of SAPHO syndrome in response to Tripterygium wilfordii hook f treatment
por: Li, Chen, et al.
Publicado: (2017)

Cloning, Expression Analysis and Functional Characterization of Squalene Synthase (SQS) from Tripterygium wilfordii
por: Zhang, Bin, et al.
Publicado: (2018)

Bibliometric analysis of trends in research of Tripterygium wilfordii Hook F for treating rheumatoid arthritis
por: Li, Wenyuan, et al.
Publicado: (2023)

Tripterygium wilfordii glycosides ameliorates collagen-induced arthritis and aberrant lipid metabolism in rats
por: Zhu, Yitian, et al.
Publicado: (2022)

Tripterygium wilfordii derivative LLDT-8 targets CD2 in the treatment of rheumatoid arthritis
por: Li, Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ampmv220j0j0k0ntrml04n1gs7